help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marsh, D. J.
Right arrow Articles by Robinson, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsh, D. J.
Right arrow Articles by Robinson, B. G.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 4 1866-1872
Copyright © 2003 by The Endocrine Society

Genome-Wide Copy Number Imbalances Identified in Familial and Sporadic Medullary Thyroid Carcinoma

Deborah J. Marsh, George Theodosopoulos, Klaus Martin-Schulte, Anne-Louise Richardson, Jeanette Philips, Hans-Dietrich Röher, Leigh Delbridge and Bruce G. Robinson

Cancer Genetics (D.J.M., G.T., A.-L.R., B.G.R.), Kolling Institute of Medical Research, and Pacific Laboratory Medicine Services, Departments of Anatomical Pathology (J.P.) and Surgery (L.D.), Royal North Shore Hospital, St. Leonards, New South Wales 2065, Australia; Departments of Molecular Medicine (D.J.M., G.T., A.-L.R., B.G.R.), Pathology (J.P.), and Medicine (B.G.R.), University of Sydney, New South Wales 2006, Australia; and Department of General and Trauma Surgery (K.M.-S., H.-D.R.), Heinrich-Heine University, 40225 Düsseldorf, Germany

Address all correspondence and requests for reprints to: Dr. Deborah J. Marsh, Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, Sydney, New South Wales 2065, Australia. E-mail: debbie_marsh{at}med.usyd.edu.au.

Medullary thyroid carcinoma (MTC) is a malignant tumor of the calcitonin-secreting parafollicular C cells of the thyroid occurring sporadically and as a component of the multiple endocrine neoplasia type 2/familial medullary thyroid carcinoma syndrome. The primary genetic cause of multiple endocrine neoplasia type 2 is germline mutation of the RET protooncogene. Somatic point mutations in RET also occur in sporadic MTC. Although RET mutation is likely sufficient to cause C-cell hyperplasia, the precursor lesion to MTC, tumor progression is thought to be due to clonal expansion caused by the accumulation of somatic events. Using the genome-scanning technique comparative genomic hybridization, we identified chromosomal imbalances that occur in MTC including deletions of chromosomes 1p, 3q26.3-q27, 4, 9q13-q22, 13q, and 22q and amplifications of chromosome 19. These regions house known tumor suppressor genes as well as genes encoding subunits of the multicomponent complex of glycosylphosphatidylinositol-linked proteins (glial cell line-derived neurotrophic factor family receptors {alpha}-2–4) and their ligands glial cell line-derived neurotrophic factor, neurturin, persephin, and artemin that facilitate RET dimerization and downstream signaling. Chromosomal imbalances in the MTC cell line TT were largely identical to those identified in primary MTC tumors, consolidating its use as a model for studying MTC.

This work was supported by Cure Cancer Australia (formerly the Leo and Jenny Leukemia and Cancer Foundation), the Ramaciotti Foundation, and the National Health and Medical Research Council (NHMRC), Australia. D.J.M. is an R. D. Wright Fellow (NHMRC, Australia).

Abbreviations: CCH, C-cell hyperplasia; CGH, comparative genomic hybridization; FMTC, familial medullary thyroid carcinoma; LOH, loss of heterozygosity; MEN 2, multiple endocrine neoplasia type 2; MTC, medullary thyroid carcinoma; VHL, von Hippel Lindau syndrome.




This article has been cited by other articles:


Home page
Cancer Res.Home page
W. van Veelen, C. J.R. van Gasteren, D. S. Acton, D. S. Franklin, R. Berger, C. J.M. Lips, and J. W.M. Hoppener
Synergistic Effect of Oncogenic RET and Loss of p18 on Medullary Thyroid Carcinoma Development
Cancer Res., March 1, 2008; 68(5): 1329 - 1337.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
R. D. Read, P. J. Goodfellow, E. R. Mardis, N. Novak, J. R. Armstrong, and R. L. Cagan
A Drosophila Model of Multiple Endocrine Neoplasia Type 2
Genetics, November 1, 2005; 171(3): 1057 - 1081.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society